Rafferty v. Merck & Co., Inc., et al. (Lawyers Weekly No. 10-041-18)
(adsbygoogle = window.adsbygoogle || []).push({});
NOTICE: All slip opinions and orders are subject to formal revision and are superseded by the advance sheets and bound volumes of the Official Reports. If you find a typographical error or other formal error, please notify the Reporter of Decisions, Supreme Judicial Court, John Adams Courthouse, 1 Pemberton Square, Suite 2500, Boston, MA, 02108-1750; (617) 557-1030; SJCReportersjc.state.ma.us
SJC-12347
BRIAN RAFFERTY vs. MERCK & CO., INC., & another.[1]
Middlesex. November 6, 2017. – March 16, 2018.
Present: Gants, C.J., Gaziano, Budd, & Cypher, JJ.
Negligence, Pharmaceutical manufacturer, Adequacy of warning, Duty to warn, Standard of care. Actionable tort. Public Policy. Consumer Protection Act, Unfair or deceptive act, Trade or commerce. Practice, Civil, Motion to dismiss.
Civil action commenced in the Superior Court Department on October 10, 2013.